Xeris Biopharma Holdings Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Mar 24 | BuyUS$9,720 | John Schmid | Individual | 4,500 | US$2.16 | |
27 Nov 23 | BuyUS$10,098 | Jeffrey Sherman | Individual | 5,400 | US$1.87 | |
20 Nov 23 | BuyUS$54,600 | Steven Pieper | Individual | 28,000 | US$1.95 | |
20 Nov 23 | BuyUS$9,954 | Dawn Halkuff | Individual | 5,410 | US$1.84 | |
17 Nov 23 | BuyUS$50,400 | John Shannon | Individual | 30,769 | US$1.64 | |
16 Nov 23 | BuyUS$9,815 | John Schmid | Individual | 6,500 | US$1.51 | |
14 Nov 23 | BuyUS$10,058 | Marla Persky | Individual | 6,370 | US$1.58 | |
09 Aug 23 | BuyUS$23,794 | Paul Edick | Individual | 10,000 | US$2.38 |
Insider Trading Volume
Insider Buying: XERS insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 27,848 | 0.0198% |
Individual Insiders | 6,233,198 | 4.44% |
Institutions | 62,915,669 | 44.8% |
General Public | 71,276,752 | 50.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,011,391 | US$18.0m | 6.8% | no data | |||
7,086,345 | US$12.7m | 0.86% | no data | |||
5,937,000 | US$10.7m | 0.37% | 5.03% | |||
5,641,920 | US$10.1m | 0% | 0.51% | |||
3,847,232 | US$6.9m | -3.53% | 1.54% | |||
3,543,685 | US$6.4m | 0% | 5.19% | |||
3,028,755 | US$5.4m | -2.46% | 0.32% | |||
2,892,077 | US$5.2m | 4.28% | no data | |||
2,724,126 | US$4.9m | 5.99% | no data | |||
1,626,912 | US$2.9m | 38.2% | no data | |||
1,621,494 | US$2.9m | 47.9% | no data | |||
1,547,955 | US$2.8m | -31.9% | no data | |||
1,381,640 | US$2.5m | 35.2% | no data | |||
1,205,746 | US$2.2m | 91.9% | no data | |||
1,165,363 | US$2.1m | 1.76% | no data | |||
1,054,610 | US$1.9m | 20.5% | no data | |||
1,046,587 | US$1.9m | 0% | 0.08% | |||
825,242 | US$1.5m | 86.8% | no data | |||
708,912 | US$1.3m | 43.7% | no data | |||
568,619 | US$1.0m | 0% | 0.13% | |||
553,411 | US$993.1k | -13.7% | 0.01% | |||
536,447 | US$962.6k | 0% | no data | |||
520,121 | US$933.3k | -11.5% | no data | |||
496,635 | US$891.2k | 199% | no data | |||
419,567 | US$752.9k | -41.1% | no data |